Clinical Trials Directory

Trials / Completed

CompletedNCT05907915

Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

PURPOSE: The purpose of the study is to evaluate the effect of (LLLT) on donor site wound healing following skin graft surgery. BACKGROUND: The skin graft is a beneficial reconstructive technique for accelerating wound healing .Managing donor site after graft harvesting is very important, and often, patients have more discomfort at the donor site than the recipient burn site itself.Using techniques that accelerate wound healing may enhance patient satisfaction. Low-level laser therapy (LLLT) has been used in several medical fields, including healing of diabetic, surgical, and pressure ulcers. Accelerating the healing process and reducing pain during healing are beneficial for the following reasons: faster return to work, lower risk of wound infection, improved quality of life, and possibly reduced need for analgesia. HYPOTHESES: It is hypothesized that: Low level laser therapy has a positive effect on donor site wound healing following skin graft surgery in burned patients. RESEARCH QUESTION: Is low level laser therapy has a positive effect on donor site healing following skin graft surgery in burned patients?

Conditions

Interventions

TypeNameDescription
DEVICElow level laser therapyThey recieved LLLT 1 session daily, 3 session per week for 3 weeks,with the following parameters( 650 nm wavelength, 150 mw power output, 0.25 cm2 radiation area, 0.6 W/cm2 power density, continuous mode, 2 j/ cm2, 90 seconds / cm2) in addition to the conventional medical treatment and traditional wound care (dressing)
BEHAVIORALplaceboThey received placebo laser 1 session daily, 3 session per week for 3 weeks in addition to the conventional medical treatment and traditional wound care (dressing)

Timeline

Start date
2022-11-01
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2023-06-18
Last updated
2023-06-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05907915. Inclusion in this directory is not an endorsement.